These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 12901556

  • 1. DNA-based vaccines for allergic disease.
    Spiegelberg HL, Takabayashi K, Beck L, Raz E.
    Expert Rev Vaccines; 2002 Aug; 1(2):169-77. PubMed ID: 12901556
    [Abstract] [Full Text] [Related]

  • 2. DNA-based approaches to the treatment of allergies.
    Spiegelberg HL, Raz E.
    Curr Opin Mol Ther; 2002 Feb; 4(1):64-71. PubMed ID: 11883696
    [Abstract] [Full Text] [Related]

  • 3. Allergen-immunostimulatory oligodeoxynucleotide conjugate: a novel allergoid for immunotherapy.
    Spiegelberg HL, Horner AA, Takabayashi K, Raz E.
    Curr Opin Allergy Clin Immunol; 2002 Dec; 2(6):547-51. PubMed ID: 14752340
    [Abstract] [Full Text] [Related]

  • 4. DNA vaccines for the prevention and treatment of allergy.
    Chua KY, Kuo IC, Huang CH.
    Curr Opin Allergy Clin Immunol; 2009 Feb; 9(1):50-4. PubMed ID: 19532092
    [Abstract] [Full Text] [Related]

  • 5. A hybrid molecule resembling the epitope spectrum of grass pollen for allergy vaccination.
    Linhart B, Hartl A, Jahn-Schmid B, Verdino P, Keller W, Krauth MT, Valent P, Horak F, Wiedermann U, Thalhamer J, Ebner C, Kraft D, Valenta R.
    J Allergy Clin Immunol; 2005 May; 115(5):1010-6. PubMed ID: 15867859
    [Abstract] [Full Text] [Related]

  • 6. [DNA vaccines against allergy].
    Sato Y, Kasukawa R.
    Nihon Rinsho; 2000 Jun; 58(6):1307-14. PubMed ID: 10879058
    [Abstract] [Full Text] [Related]

  • 7. Strategies for the development of safe and effective DNA vaccines for allergy treatment.
    Hartl A, Weiss R, Hochreiter R, Scheiblhofer S, Bauer R, Valenta R, Ferreira F, Leitner W, Thalhamer J.
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2003 Jun; (94):279-98; discussion 299. PubMed ID: 15119049
    [Abstract] [Full Text] [Related]

  • 8. Progress in the development of new methods of immunotherapy: potential application of immunostimulatory DNA-conjugated to allergens for treatment of allergic respiratory conditions.
    Creticos PS, Lichtenstein LM.
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2003 Jun; (94):304-12; discussion 312-3. PubMed ID: 15119051
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. DNA vaccines for allergy treatment.
    Weiss R, Scheiblhofer S, Thalhamer J.
    Methods Mol Med; 2006 Jun; 127():253-67. PubMed ID: 16988459
    [Abstract] [Full Text] [Related]

  • 11. DNA vaccines for allergy treatment.
    Hartl A, Weiss R, Hochreiter R, Scheiblhofer S, Thalhamer J.
    Methods; 2004 Mar; 32(3):328-39. PubMed ID: 14962768
    [Abstract] [Full Text] [Related]

  • 12. Genetic allergen modification in the development of novel approaches to specific immunotherapy.
    Mutschlechner S, Deifl S, Bohle B.
    Clin Exp Allergy; 2009 Nov; 39(11):1635-42. PubMed ID: 19624521
    [Abstract] [Full Text] [Related]

  • 13. DNA vaccine encoding Der p 2 allergen generates immunologic protection in recombinant Der p 2 allergen-induced allergic airway inflammation mice model.
    Li GP, Liu ZG, Qiu J, Ran PX, Zhong NS.
    Chin Med J (Engl); 2005 Apr 05; 118(7):534-40. PubMed ID: 15820083
    [Abstract] [Full Text] [Related]

  • 14. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.
    Trujillo-Vargas CM, Mayer KD, Bickert T, Palmetshofer A, Grunewald S, Ramirez-Pineda JR, Polte T, Hansen G, Wohlleben G, Erb KJ.
    Clin Exp Allergy; 2005 Aug 05; 35(8):1003-13. PubMed ID: 16120081
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Strategies for converting allergens into hypoallergenic vaccine candidates.
    Vrtala S, Focke-Tejkl M, Swoboda I, Kraft D, Valenta R.
    Methods; 2004 Mar 05; 32(3):313-20. PubMed ID: 14962766
    [Abstract] [Full Text] [Related]

  • 17. Immune mechanisms of allergen-specific sublingual immunotherapy.
    Moingeon P, Batard T, Fadel R, Frati F, Sieber J, Van Overtvelt L.
    Allergy; 2006 Feb 05; 61(2):151-65. PubMed ID: 16409190
    [Abstract] [Full Text] [Related]

  • 18. Molecular approaches for new vaccines against allergy.
    Niederberger V, Valenta R.
    Expert Rev Vaccines; 2006 Feb 05; 5(1):103-10. PubMed ID: 16451112
    [Abstract] [Full Text] [Related]

  • 19. Biotechnology-based allergy diagnosis and vaccination.
    Bhalla PL, Singh MB.
    Trends Biotechnol; 2008 Mar 05; 26(3):153-61. PubMed ID: 18222557
    [Abstract] [Full Text] [Related]

  • 20. Allergen immunotherapy: novel approaches in the management of allergic diseases and asthma.
    Campbell D, DeKruyff RH, Umetsu DT.
    Clin Immunol; 2000 Dec 05; 97(3):193-202. PubMed ID: 11112358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.